Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
What is Vitritis and How to Manage it?
Vitritis is an ocular condition characterized by inflammation of the vitreous, a gel-like substance filling the eyeball behind the lens and in front of the retina. This inflammation can be due to various causes, including infections, autoimmune diseases, or trauma…
What is Schirmer’s Test and How to Conduct it
In the dynamic landscape of ophthalmology, the evaluation of tear production holds a central position in understanding and managing a spectrum of ocular conditions. Among the various tools available, Schirmer’s Test, named after the pioneering German ophthalmologist Otto Schirmer, stands…
VSY Unveils Enova Advanced EDoF IOL at EPOMEC 2023
VSY Biotechnology, a leading company in ophthalmic innovations, made a notable presence at the 10th Evolving Practice of Ophthalmology Middle East Conference (EPOMEC 2023) in Dubai. The conference, held from 23-25 November, marked a significant moment for VSY Biotechnology as…
Role of Corneal Hysteresis in Glaucoma Risk Assessment
What is Corneal Hysteresis? Corneal hysteresis is a measure of the cornea’s ability to absorb and dissipate energy when subjected to stress, such as the pressure exerted within the eye. The cornea is the clear, dome-shaped front surface of the…
EyeBio Raises $130M for Restoret Development
EyeBio announced the successful completion of an extension to its Series A financing, resulting in a total raised amount of $130 million to date. The funding will be utilized by EyeBio to accelerate the company’s clinical development program and expand…
Ocutrx Unveils OcuLenz AR/XR Headset for Advanced AMD
Ocutrx Technologies has launched the OcuLenz AR/XR headset, a cutting-edge device specifically engineered to elevate visual clarity and redefine the possibilities for those with advanced age-related macular degeneration. The OcuLenz AR/XR headset distinguishes itself with its lightweight and user-friendly design.…
FDA Warns Amazon Over Sale of 7 Unapproved Eye Drops
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has issued a warning letter to e-commerce giant Amazon.com regarding the introduction of unapproved ophthalmic drug products into interstate commerce. The FDA’s warning, delivered in a…
CHMP Backs Bayer’s High-Dose Eylea for Retinal Diseases
Bayer announced on Friday that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of a high-dose formulation of the renowned eye drug Eylea for the treatment of wet age-related macular degeneration and…
VSY Biotechnology to Introduce a Novel Anti-VEGF for AMD
VSY Biotechnology GmbH is proud to announce the groundbreaking development of Varliciment, a revolutionary anti-VEGF agent for the treatment of age-related macular degeneration (AMD). Varliciment distinguishes itself from existing anti-VEGF agents like brolucizumab, namely Novartis’ Beovu, by being non-generic. This…
Visionix USA Announces Strategic Alliance with 20/20NOW
Visionix USA has formed a strategic alliance with 20/20NOW, with the objective of making affordable, in-office, synchronous tele-optometry eye exams and ocular telemedicine more accessible to a broader range of patients across the United States. The financial terms of the…